NASDAQ:BBLG Bone Biologics (BBLG) Stock Price, News & Analysis → Elon’s New A.I. Device is About to Shock the World (From InvestorPlace) (Ad) Free BBLG Stock Alerts $1.60 +0.07 (+4.25%) (As of 02:03 PM ET) Add Compare Share Share Today's Range$1.55▼$1.6450-Day Range$1.53▼$3.9052-Week Range$1.46▼$72.00Volume16,106 shsAverage Volume98,679 shsMarket Capitalization$845,350.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media Get Bone Biologics alerts: Email Address Ad InvestorPlaceElon’s New A.I. Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. About Bone Biologics Stock (NASDAQ:BBLG)Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.Read More BBLG Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BBLG Stock News HeadlinesMarch 6, 2024 | businesswire.comBone Biologics Announces Closing of $2.0 Million Public OfferingMarch 4, 2024 | businesswire.comBone Biologics Announces Pricing of $2.0 Million Public OfferingApril 29, 2024 | InvestorPlace (Ad)Have You Seen Elon’s New A.I. Device? (Picture Inside)A strange new era for mankind is upon us... And it's all thanks to Elon Musk's latest creation. Click here to see this strange device you could be wearing some day. Elon believes A.I. is advancing so fast...March 1, 2024 | businesswire.comBone Biologics Reports Progress With NB1 Clinical ProgramJanuary 10, 2024 | finance.yahoo.comBone Biologics Regains Compliance with Nasdaq Continued Listing RequirementsDecember 28, 2023 | benzinga.comTrump-Linked SPAC Digital World Acquisition, Bone Biologics, Redwood Trust, Baidu, Tesla — Why These 5 Stocks Are On Investors' Radars TodaySee More Headlines Receive BBLG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bone Biologics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/29/2024Next Earnings (Estimated)5/20/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical appliances & supplies Sub-IndustryN/A Current SymbolNASDAQ:BBLG Previous SymbolNASDAQ:BBLG CUSIPN/A CIK1419554 Webwww.bonebiologics.com Phone781-552-4452FaxN/AEmployees2Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($49.68) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-8,950,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-236.06% Return on Assets-154.82% Debt Debt-to-Equity RatioN/A Current Ratio4.50 Quick Ratio4.50 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$7.42 per share Price / Book0.21Miscellaneous Outstanding Shares530,000Free Float465,000Market Cap$845,350.00 OptionableNot Optionable Beta0.18 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMr. Jeffrey Frelick (Age 58)CEO & President Comp: $325kMs. Deina H. Walsh (Age 60)Chief Financial Officer Comp: $212.5kDr. Shun'ichi KurodaCo-Founder & Member of Scientific Advisory BoardKey CompetitorsSientraNASDAQ:SIENQNanoVibronixNASDAQ:NAOVEvofem BiosciencesNASDAQ:EVFMHumanigenNASDAQ:HGENAcorda TherapeuticsNASDAQ:ACORView All CompetitorsInsidersDeina H WalshBought 1,000 shares on 9/13/2023Total: $5,120.00 ($5.12/share)Jeff FrelickBought 1,187 shares on 9/11/2023Total: $6,552.24 ($5.52/share)Deina H WalshBought 875 shares on 9/6/2023Total: $4,970.00 ($5.68/share)Jeff FrelickBought 950 shares on 8/31/2023Total: $5,016.00 ($5.28/share)View All Insider Transactions BBLG Stock Analysis - Frequently Asked Questions How have BBLG shares performed in 2024? Bone Biologics' stock was trading at $4.52 at the beginning of the year. Since then, BBLG shares have decreased by 64.7% and is now trading at $1.5950. View the best growth stocks for 2024 here. Are investors shorting Bone Biologics? Bone Biologics saw a decrease in short interest during the month of April. As of April 15th, there was short interest totaling 13,000 shares, a decrease of 13.9% from the March 31st total of 15,100 shares. Based on an average daily trading volume, of 80,600 shares, the short-interest ratio is presently 0.2 days. Approximately 2.6% of the company's stock are short sold. View Bone Biologics' Short Interest. When is Bone Biologics' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024. View our BBLG earnings forecast. When did Bone Biologics' stock split? Shares of Bone Biologics reverse split on the morning of Wednesday, December 20th 2023. The 1-8 reverse split was announced on Wednesday, December 20th 2023. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, December 20th 2023. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split. When did Bone Biologics IPO? Bone Biologics (BBLG) raised $8 million in an initial public offering (IPO) on Wednesday, October 13th 2021. The company issued 1,510,455 shares at $5.25 per share. How do I buy shares of Bone Biologics? Shares of BBLG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:BBLG) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsAI finds its first serious applicationWall Street StarThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press4 coins to be the “Next Bitcoin”True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bone Biologics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
